Verified peer comparison
Adaptive Biotechnologies Corporation - Common Stock vs Viking Therapeutics Financial Comparison
Adaptive Biotechnologies Corporation - Common Stock versus Viking Therapeutics…
Direct answer
Adaptive Biotechnologies Corporation - Common Stock and Viking Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- Adaptive Biotechnologies Corporation - Common Stock Revenue
- 276,976,000 USD
- Viking Therapeutics Revenue
- 0 USD
- Adaptive Biotechnologies Corporation - Common Stock Operating income
- -57,123,000 USD
- Viking Therapeutics Operating income
- -393,342,000 USD